insulin drugs glp 1 receptor agonist market Global GLP-1 Size, Forecast GLP-1 Receptor Agonist Market: Exploring
Description
An endocrinologist explains who the pill is right for in the UAE, what the trial numbers actually say, and when the injection still wins.
The best results happen when the medicine is used along with healthy eating and exercise, and people may gain weight back if they stop taking the medicine
Emanuel EJ, Dellgren JL, McCoy MS
Glucagon-like peptide-1 receptor agonists (GLP-1RAs), initially developed for diabetes and obesity, exhibit pleiotropic effectsincluding anti-inflammatory, ...
For patients, oral therapies promise greater convenience, improved adherence, and broader access, particularly for those reluctant to use injectables
